Symbol: |
GABRA2
|
Description: |
gamma-aminobutyric acid (GABA) A receptor, alpha 2 [Source:HGNC Symbol;Acc:4076]
|
Location: |
Chr4:46250444-46477247[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:172
Gene |
Compound |
Gen_sig |
Exp_pattern |
GABRA2 |
NSC 49713 |
0.02 |
Up |
GABRA2 |
C.I. 37559 |
0.028 |
Down |
GABRA2 |
NSC 527353 |
0.001 |
Up |
GABRA2 |
9-AC |
0.032 |
Down |
GABRA2 |
Camptothecin ethylglycinate ester hydrochloride |
0.022 |
Down |
GABRA2 |
Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt |
0.033 |
Down |
GABRA2 |
Camptothecin hemisuccinate sodium salt |
0.033 |
Down |
GABRA2 |
Imidazole, 1-(4-chlorophenyl)-4-(4-nitrophenyl)- |
0.005 |
Down |
GABRA2 |
Benzo[1,2-c:4,5-c']dipyrrole-1,3,5,7(2H,6H)-tetraimine |
0.049 |
Up |
GABRA2 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.02 |
Down |
GABRA2 |
2-Propen-1-one, 3-(l,3-benzodioxol-5-yl)-1-(1,4-dioxo- 2,6,7-trimethylquinoxalin-3-yl)- |
0.043 |
Down |
GABRA2 |
NSC 62349 |
0.007 |
Down |
GABRA2 |
Imidazo[2,1-b]thiazole-5-carboxamide, N-[(4-chlorophenyl)-aminocarbonyl]- |
0.014 |
Down |
GABRA2 |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.006 |
Down |
GABRA2 |
23,27-Epoxy-3H-pyrido[2,1-c] [1,4]oxaazacyclohentriacontine-1,5,11,28,29-pentone-, 1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31, 32,33,34,34a-tetracosahydro- 27-hydroxy-10,21-dimethoxy-3-[2-[3-methoxy-4-[1-oxo- 3-(dimethylamino)propoxy]cyclohexy |
0.047 |
Down |
Expression pattern: Sensitivity / Resistance
Total:12 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:57
Total:4 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:56
Total:4 Current:1
[First] [Prev]  Next Last 
|